An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors
An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors
About this item
Full title
Author / Creator
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
More information
Scope and Contents
Contents
The anticancer drugs screening program is a long and expensive process. It is estimated that only 5% of drugs entering clinical trials are approved by the FDA. Moreover, many of the drugs that enter clinical trials are often of limited use in clinical practice, and most cancers remain untreatable. Brain tumors are particularly difficult to treat du...
Alternative Titles
Full title
An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3398605
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3398605
Other Identifiers
ISSN
2090-5165,2090-5173
E-ISSN
2090-5173
DOI
10.5402/2012/513580
